Gamma interferon (IFN-γ) receptor restricts systemic dengue virus replication and prevents paralysis in IFN-α/β receptor-deficient mice
- PMID: 22973027
- PMCID: PMC3497655
- DOI: 10.1128/JVI.06743-11
Gamma interferon (IFN-γ) receptor restricts systemic dengue virus replication and prevents paralysis in IFN-α/β receptor-deficient mice
Abstract
We previously reported that mice lacking alpha/beta and gamma interferon receptors (IFN-α/βR and -γR) uniformly exhibit paralysis following infection with the dengue virus (DENV) clinical isolate PL046, while only a subset of mice lacking the IFN-γR alone and virtually no mice lacking the IFN-α/βR alone develop paralysis. Here, using a mouse-passaged variant of PL046, strain S221, we show that in the absence of the IFN-α/βR, signaling through the IFN-γR confers approximately 140-fold greater resistance against systemic vascular leakage-associated dengue disease and virtually complete protection from dengue-induced paralysis. Viral replication in the spleen was assessed by immunohistochemistry and flow cytometry, which revealed a reduction in the number of infected cells due to IFN-γR signaling by 2 days after infection, coincident with elevated levels of IFN-γ in the spleen and serum. By 4 days after infection, IFN-γR signaling was found to restrict DENV replication systemically. Clearance of DENV, on the other hand, occurred in the absence of IFN-γR, except in the central nervous system (CNS) (brain and spinal cord), where clearance relied on IFN-γ from CD8(+) T cells. These results demonstrate the roles of IFN-γR signaling in protection from initial systemic and subsequent CNS disease following DENV infection and demonstrate the importance of CD8(+) T cells in preventing DENV-induced CNS disease.
Figures
Similar articles
-
Characterization of lethal dengue virus type 4 (DENV-4) TVP-376 infection in mice lacking both IFN-α/β and IFN-γ receptors (AG129) and comparison with the DENV-2 AG129 mouse model.J Gen Virol. 2015 Oct;96(10):3035-3048. doi: 10.1099/jgv.0.000246. Epub 2015 Jul 14. J Gen Virol. 2015. PMID: 26296350 Free PMC article.
-
STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor.PLoS Pathog. 2011 Feb;7(2):e1001297. doi: 10.1371/journal.ppat.1001297. Epub 2011 Feb 17. PLoS Pathog. 2011. PMID: 21379341 Free PMC article.
-
The roles of IRF-3 and IRF-7 in innate antiviral immunity against dengue virus.J Immunol. 2013 Oct 15;191(8):4194-201. doi: 10.4049/jimmunol.1300799. Epub 2013 Sep 16. J Immunol. 2013. PMID: 24043884 Free PMC article.
-
Mouse models of dengue virus infection for vaccine testing.Vaccine. 2015 Dec 10;33(50):7051-60. doi: 10.1016/j.vaccine.2015.09.112. Epub 2015 Oct 23. Vaccine. 2015. PMID: 26478201 Free PMC article. Review.
-
Influence of antibodies and T cells on dengue disease outcome: insights from interferon receptor-deficient mouse models.Curr Opin Virol. 2015 Aug;13:61-6. doi: 10.1016/j.coviro.2015.04.007. Epub 2015 May 23. Curr Opin Virol. 2015. PMID: 26001278 Review.
Cited by
-
Genome tuning through HLA and KIR gene clusters impact susceptibility to dengue.Infect Med (Beijing). 2023 May 11;2(3):167-177. doi: 10.1016/j.imj.2023.05.001. eCollection 2023 Sep. Infect Med (Beijing). 2023. PMID: 38073888 Free PMC article. Review.
-
Respiratory syncytial virus-like nanoparticle vaccination induces long-term protection without pulmonary disease by modulating cytokines and T-cells partially through alveolar macrophages.Int J Nanomedicine. 2015 Jul 14;10:4491-505. doi: 10.2147/IJN.S83493. eCollection 2015. Int J Nanomedicine. 2015. PMID: 26203246 Free PMC article.
-
Protective Role of Cross-Reactive CD8 T Cells Against Dengue Virus Infection.EBioMedicine. 2016 Nov;13:284-293. doi: 10.1016/j.ebiom.2016.10.006. Epub 2016 Oct 7. EBioMedicine. 2016. PMID: 27746192 Free PMC article.
-
Immunomodulation in dengue: towards deciphering dengue severity markers.Cell Commun Signal. 2024 Sep 26;22(1):451. doi: 10.1186/s12964-024-01779-4. Cell Commun Signal. 2024. PMID: 39327552 Free PMC article. Review.
-
Ideal Criteria for Accurate Mouse Models of Vector-Borne Diseases with Emphasis on Scrub Typhus and Dengue.Am J Trop Med Hyg. 2020 Sep;103(3):970-975. doi: 10.4269/ajtmh.19-0955. Am J Trop Med Hyg. 2020. PMID: 32602433 Free PMC article. Review.
References
-
- An J, Zhou DS, Kawasaki K, Yasui K. 2003. The pathogenesis of spinal cord involvement in dengue virus infection. Virchows Arch. 442:472–481 - PubMed
-
- Angibaud G, Luaute J, Laille M, Gaultier C. 2001. Brain involvement in dengue fever. J. Clin. Neurosci. 8:63–65 - PubMed
-
- Atrasheuskaya A, Petzelbauer P, Fredeking TM, Ignatyev G. 2003. Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection. FEMS Immunol. Med. Microbiol. 35:33–42 - PubMed
-
- Balsitis SJ, et al. 2010. Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog. 6:e1000790 doi:10.1371/journal.ppat.1000790 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials